Clinical Trial Update: Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Omegapres to a solifenacin and mirabegron combination for primary nocturnal enuresis in children is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturnal Enuresis

Drugs mentioned

• Mirabegron (mirabegron)
• Omegapres
• Solifenacin (solifenacin)

Snippet

Sponsor: Mansoura University | Conditions: Nocturnal Enuresis in Children | Phase 3 | Status: RECRUITING